MDB Capital Holdings, LLC Class A (MDBH)
NASDAQ:MDBH
Top Page
MDB Capital Holdings, LLC Class A
(NASDAQ:MDBH)
Select Model
Select Model
Rating:52Neutral
Price Target:
$3.00
▼(-14.77% Downside)
Action:ReiteratedDate:04/02/26
The score is held down primarily by weak financial performance (revenue collapsing to zero, losses, and persistent negative operating/free cash flow) despite low leverage. Technicals show only a modest short-term rebound within a weaker longer-term trend, valuation is constrained by a negative P/E and no dividend support, while the earnings call adds some upside from AI-driven efficiency and scaling plans but with significant execution and financing uncertainties.
Positive Factors
Conservative balance sheet and liquidity
Low leverage and a cash-rich stance materially reduce solvency risk and extend strategic optionality. With minimal debt and a reported cash cushion, the company can pursue launches, partner talks, or spinouts without immediate refinancing pressure, improving runway for execution.
Negative Factors
Revenue collapse and volatile profitability
A drop to zero revenue is a structural red flag for a fee-driven capital markets business: without consistent transaction flow, core economics cannot scale. Persistent swings in profitability undermine reinvestment capacity and make long-term forecasting and client retention harder.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet and liquidity
Low leverage and a cash-rich stance materially reduce solvency risk and extend strategic optionality. With minimal debt and a reported cash cushion, the company can pursue launches, partner talks, or spinouts without immediate refinancing pressure, improving runway for execution.
Read all positive factors
MDB Capital Holdings, LLC Class A (MDBH) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$37.69M
Dividend YieldN/A
Average Volume (3M)15.20K
Price to Earnings (P/E)―
Beta (1Y)0.15
Revenue Growth121.21%
EPS GrowthN/A
CountryUS
Employees16
SectorFinancial
Sector Strength70
IndustryFinancial - Capital Markets
Share Statistics
EPS (TTM)-0.17
Shares Outstanding5,300,132
10 Day Avg. Volume19,179
30 Day Avg. Volume15,201
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.54
Price to Sales (P/S)7.61
P/FCF Ratio-5.68
Enterprise Value/Market Cap0.64
Enterprise Value/Revenue5.62
Enterprise Value/Gross Profit-2.25
Enterprise Value/Ebitda-1.45
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
MDB Capital Holdings, LLC Class A Business Overview & Revenue Model
Company Description
MDB Capital Holdings, LLC, through its subsidiaries, primarily operates as a broker-dealer. The company operates through two segments, Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Prop...
How the Company Makes Money
MDBH makes money primarily through fees generated by its investment banking and capital markets activities. Key revenue streams generally include: (1) advisory fees for corporate finance and strategic transactions (e.g., merger and acquisition adv...
MDB Capital Holdings, LLC Class A Earnings Call Summary
Earnings Call Date:Mar 31, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:May 27, 2026
Earnings Call Sentiment Neutral
The call emphasized significant operational progress and strategic positioning (notably rapid AI-driven diligence improvements, building two discrete monetizable assets in MDB Direct and PatentVest, a clearer path to lower run-rate OpEx, and a sizable pipeline with several assets that management believes have $1B potential). However, the company faces material near-term challenges: a prolonged public stock decline, difficult microcap market conditions, a critical distribution gap needed to scale launches, execution issues at some portfolio companies, and ongoing financing/valuation uncertainty for spinouts. The tone is optimistic about future scalability but pragmatic about the risks and uncertainty in execution and market reception.Positive Updates
AI-Driven Diligence Acceleration
Management reports AI reduced diligence inertia dramatically: they estimate compressing time-to-answer by ~2/3 (≈66.7%). Patentability analyses that previously took ~45 hours are now done in ~1.5 hours (≈96.7% faster). S-1 preparation that historically took 6–18 months is expected to be achievable in weeks, enabling far faster company launches.
Negative Updates
Public Market and Share Performance Headwinds
Management acknowledged a prolonged stock decline since IPO and difficult microcap market conditions that have impacted valuations and investor appetite. eXoZymes' market value of the company's holding fell from ~ $45M at year-end to ~ $30M currently (≈33% decline). Overall investor base engagement is limited: the company has 'a couple thousand' shareholders but only ~675 active accounts (≈33% active if base ≈2,000), constraining distribution reach.
Read all updates
Q4-2025 Updates
Positive
Negative
AI-Driven Diligence Acceleration
Management reports AI reduced diligence inertia dramatically: they estimate compressing time-to-answer by ~2/3 (≈66.7%). Patentability analyses that previously took ~45 hours are now done in ~1.5 hours (≈96.7% faster). S-1 preparation that historically took 6–18 months is expected to be achievable in weeks, enabling far faster company launches.
Read all positive updates
Company Guidance
MDB said it plans to scale from its historic cadence of one launch every 18 months to 3–5 launches per year, driven by AI gains over the past 90–120 days that it says can compress diligence by ~2/3 (example: patentability reviews from ~45 hours to ~1.5 hours) and cut IPO prep from 6–18 months to weeks. Financially, management reported ~ $10M in fixed OpEx, $5.7M cash burn for the year (including ~ $4M invested annually since the IPO in MDB Direct and PatentVest), which implies a pro‑forma burn of ~ $1.7M after excluding those investments and a projected post‑spinout OpEx of ~ $6M/year; cash and marketable securities less current liabilities totaled ~ $22.3M at year‑end. Portfolio metrics cited: eXoZymes ~ $45M year‑end market value (current stake ≈ $30M), 7.1M Paulex shares (IPO and planned clinical trial this year), a U.S. patent‑prosecution TAM of $10–15B, 18 historical IPOs over 29 years, ~675 active accounts out of a few thousand shareholders, and management’s view that each principal asset has potential to reach a $1B valuation.MDB Capital Holdings, LLC Class A Financial Statement Overview
Summary
Income Statement
22
Negative
Balance Sheet
74
Positive
Cash Flow
28
Negative
| Breakdown | Dec 2025 | Mar 2025 | Mar 2024 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 4.28M | 2.22M | 4.23M | 1.12M | 0.00 |
| Gross Profit | -10.69M | -17.84M | -4.39M | -1.71M | -1.97M |
| EBITDA | -16.95M | 12.33M | -9.76M | -5.97M | -5.67M |
| Net Income | -21.25M | 11.69M | -6.97M | -5.31M | -15.10M |
Balance Sheet | |||||
| Total Assets | 63.74M | 71.98M | 42.99M | 25.70M | 8.25M |
| Cash, Cash Equivalents and Short-Term Investments | 13.22M | 20.44M | 6.11M | 4.95M | 6.23M |
| Total Debt | 609.00K | 711.50K | 2.42M | 1.42M | 720.63K |
| Total Liabilities | 3.16M | 1.90M | 5.67M | 2.59M | 1.49M |
| Stockholders Equity | 60.69M | 70.16M | 37.31M | 22.64M | 6.24M |
Cash Flow | |||||
| Free Cash Flow | -5.73M | -8.49M | -7.60M | -6.77M | -6.26M |
| Operating Cash Flow | -5.68M | -9.04M | -7.16M | -6.57M | -5.83M |
| Investing Cash Flow | -49.00K | 22.89M | -8.20M | -16.38M | -423.39K |
| Financing Cash Flow | 0.00 | 69.30K | 17.76M | 21.68M | 0.00 |
MDB Capital Holdings, LLC Class A Technical Analysis
Positive
3.52
Price Trends
3.08
Positive
3.25
Positive
3.55
Positive
Market Momentum
0.10
Negative
72.85
Negative
98.75
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MDBH, the sentiment is Positive. The current price of 3.52 is above the 20-day moving average (MA) of 3.04, above the 50-day MA of 3.08, and below the 200-day MA of 3.55, indicating a bullish trend. The MACD of 0.10 indicates Negative momentum. The RSI at 72.85 is Negative, neither overbought nor oversold. The STOCH value of 98.75 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for MDBH.
MDB Capital Holdings, LLC Class A Risk Analysis
MDB Capital Holdings, LLC Class A disclosed 79 risk factors in its most recent earnings report. MDB Capital Holdings, LLC Class A reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
MDB Capital Holdings, LLC Class A Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $46.06M | 2.83 | 31.32% | 6.45% | 214.07% | -40.88% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
54 Neutral | $72.47M | -79.41 | 5.65% | ― | 8.47% | -32.22% | |
52 Neutral | $37.69M | -4.70 | 17.65% | ― | 121.21% | ― | |
52 Neutral | $65.13M | -3.15 | 116.21% | ― | ― | ― |
* Financial Sector Average
MDBH
MDB Capital Holdings, LLC Class A
3.66
-1.21
-24.87%
COHN
Cohen & Company
18.81
13.73
270.49%
SIEB
Siebert Financial
1.77
-1.22
-40.80%
DOMH
Dominari Holdings
2.88
-0.55
-16.08%
TOP
Zhong Yang Financial Group Ltd.
0.75
-0.40
-34.61%
GSIW
Garden Stage Ltd.
18.81
-63.23
-77.07%
MDB Capital Holdings, LLC Class A Corporate Events
Executive/Board Changes
MDB Capital Holdings appoints new independent audit director
Positive
Feb 2, 2026
On February 1, 2026, MDB Capital Holdings, LLC appointed 73-year-old investment veteran Jeb Terry Sr. as an independent director and member of its audit committee, with his initial term running until the company’s next annual meeting of stoc...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.